This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.81% per year. These returns cover a period from January 1, 1988 through September 1, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
New York-based Coty Inc., along with its subsidiaries, manufactures, markets, and distributes beauty products worldwide. The company sells its products through retailers, including hypermarkets, supermarkets, independent and chain drug stores and pharmacies, upscale perfumeries, upscale and mid-tier department stores, nail salons, specialty retailers, duty-free shops and traditional food, and drug and mass retailers. It also markets products under the Astor, Coty, Joop!, Jovan, Manhattan, and N.Y.C. New York Color brands.
Factors to Note as TreeHouse Foods (THS) Readies for Q3 Earnings
by Zacks Equity Research
TreeHouse Foods' (THS) third-quarter results are likely to reflect elevated commodity costs, while recovery in the away-from-home food channel is likely to have been an upside.
Freshpet (FRPT) to Post Q3 Earnings: What Awaits the Stock?
by Zacks Equity Research
Freshpet's (FRPT) third-quarter performance is likely to have gained from strong consumption trends. However, rising labor and beef costs are likely to be a drag.
Can Monster Beverage (MNST) Beat Q3 Earnings Amid Supply Woes?
by Zacks Equity Research
Monster Beverage (MNST) Q3 results are expected to reflect benefits from strength in the energy drinks category. Supply-chain disruptions are likely to have marred the company's performance.
Factors to Consider as Medifast (MED) Gears Up for Q3 Earnings
by Zacks Equity Research
Medifast's (MED) third-quarter results are likely to reflect gains from the OPTAVIA lifestyle solution and coaching support system, though high costs are a concern.
Coty (COTY) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
by Zacks Equity Research
Coty (COTY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Kellogg (K) Queued Up for Q3 Earnings: Things to Keep in Mind
by Zacks Equity Research
Kellogg's (K) third-quarter 2021 results are likely to reflect gains from a revival in the away-from-home channel. However, continued softness in at-home demand is a concern.
What's in Store for The Estee Lauder Companies (EL) Q1 Earnings?
by Zacks Equity Research
The Estee Lauder Companies' (EL) first-quarter fiscal 2022 performance is likely to reflect strength in online business. However, a rise in operating expenses might be a concern.
Factors to Consider as Nu Skin (NUS) Gears Up for Q3 Earnings
by Zacks Equity Research
Nu Skin's (NUS) third-quarter results are likely to reflect the impact of delta variant across various markets, though focus on enhancing sales leaders has been a driver.
Inter Parfums (IPAR) Raises 2021 View Again on Solid Q3 Sales
by Zacks Equity Research
Inter Parfums (IPAR) reported record sales numbers for the third quarter of 2021, reflecting impressive brand performance. Also, management revises 2021 view upward.
Coty (COTY) Gains on Strength in Partnerships & Core Priorities
by Zacks Equity Research
Coty (COTY) focuses on undertaking several strategic partnerships to enhance its brand portfolio. The company's e-commerce business is performing impressively.
Ulta Beauty (ULTA) Looks Great: 6 Core Strategies a Key Driver
by Zacks Equity Research
Ulta Beauty (ULTA) has been benefiting from its focus on six key strategies like solidifying omnichannel business. Apart from this, the company's skincare business has been a driver.
The Estee Lauder Companies (EL) Gains on Online & Skin Care Sales
by Zacks Equity Research
Strength in The Estee Lauder Companies' (EL) Skin Care portfolio is a major driver. Also, the company is implementing stringent cost-curtailment practices.
Nu Skin's (NUS) Solid Innovations Aid, Pandemic-Led Hurdles Hurt
by Zacks Equity Research
Nu Skin (NUS) is benefiting from effective product launches. However, the company is battling challenges stemming from the spread of the delta variant across several markets.
Zacks Industry Outlook Highlights: Estee Lauder, Coty. Helen of Troy and Inter Parfums
by Zacks Equity Research
Zacks Industry Outlook Highlights: Estee Lauder, Coty. Helen of Troy and Inter Parfums
4 Cosmetics Stocks Looking Good on Favorable Demand Trends
by Vidya Nair
The Zacks Cosmetics industry gains on higher demand amid consumers' increased outdoor movement. Such trends along with product launches are aiding companies like Estee Lauder (EL), Coty (COTY), Helen of Troy (HELE) and Inter Parfums (IPAR).
Nu Skin (NUS) Lowers Q3 Revenue View Amid Pandemic-Led Hurdles
by Zacks Equity Research
Nu Skin (NUS) expects Q3 revenues in the band of $637-$642 million, lower than the previous range. Challenges caused by the delta variant across several markets are a downside.
Coty (COTY) Unveils Plans to Offload 9% Stake in Wella To KKR
by Zacks Equity Research
Coty (COTY) signs an agreement to offload nearly 9% stake in Wella to KKR. Through the deal, management expects to simplify Coty's capital structure.
Coty (COTY) Teams Up With Perfect Corp. to Accelerate Growth
by Zacks Equity Research
Coty (COTY) signs a multi-channel agreement with Perfect Corp. to help customers shop in the most convenient and personalized manner both online and offline.
The Estee Lauder Companies (EL) Gains on Skin Care, Online Strength
by Zacks Equity Research
The Estee Lauder Companies (EL) is implementing new technology and digital experiences to boost growth. Also, the company's Skin Care portfolio is performing well.
Inter Parfums (IPAR) Benefits From Alliances & Product Launches
by Zacks Equity Research
Inter Parfums (IPAR) is focused on product launches that will boost assortment strength. The company concentrates on expanding its business through new licenses and acquisitions.
Coty (COTY) More Than Doubles in a Year: Will Momentum Stay?
by Zacks Equity Research
Coty (COTY) is focused on its core strategies that include achieving solid e-commerce momentum, strengthening presence in China and solidifying its foothold in the prestige category.
The Estee Lauder Companies (EL) Up More than 25% YTD: Will it Stay?
by Zacks Equity Research
The Estee Lauder Companies' (EL) Skin Care portfolio is performing well. The company's solid online business is yielding amid pandemic-led hurdles.
Coty (COTY) Q4 Loss Wider Than Estimates, Revenues Increase
by Zacks Equity Research
Coty's (COTY) fourth-quarter fiscal 2021 results reflect higher revenues on growth across all regions and channels. However, loss in the quarter was wider than the consensus mark.
Coty's (COTY) Q4 Earnings in Focus: Everything You Should Know
by Zacks Equity Research
Coty's (COTY) fourth-quarter fiscal 2021 performance is likely to reflect gains from solid e-commerce business. However, higher commercial investments are a concern.
Coty (COTY) Looks Strong: Stock Up More Than 30% in Six Months
by Zacks Equity Research
Coty's (COTY) strategic partnerships are enhancing its brand portfolio. The company is also on track with six priorities aimed at sustainable growth.